Search
Piboserod
go.drugbank.com/drugs/DB04873InvestigationalPiboserod (SB 207266) is a selective 5-HT(4) receptor antagonist.
TAFA-93
go.drugbank.com/drugs/DB05887Experimental, the treatment of autoimmune and oncological diseases, and as a component of coated stents for the treatment of coronary artery disease. … TAFA93 is a novel prodrug of the mTOR inhibitor rapamycin which has successfully completed Phase 1 clinical development. mTOR inhibitors are currently used in the prevention of organ rejection in transplantation
Marstacimab
go.drugbank.com/drugs/DB17725ApprovedInvestigational[L51803] It is a tissue factor pathway inhibitor (TFPI) antagonist, which is an endogenous anticoagulant. … Marstacimab is a human monoclonal immunoglobulin G Type 1 (IgG1) antibody produced by Chinese hamster ovary (CHO) cells by recombinant DNA technology.
Aloe vera flower
go.drugbank.com/drugs/DB14254ApprovedAloe vera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Corydalis ambigua tuber
go.drugbank.com/drugs/DB14279ApprovedCorydalis ambigua tuber is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Yan Hu Suo (Corydalis Ambigua)Lonicera caprifolium flower
go.drugbank.com/drugs/DB14280ApprovedLonicera caprifolium flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Larix sibirica wood
go.drugbank.com/drugs/DB14289ApprovedWithdrawnLarix sibirica wood is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Apricot kernel oil
go.drugbank.com/drugs/DB14324ApprovedApricot kernel oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Azadirachta indica leaf
go.drugbank.com/drugs/DB14352ApprovedAzadirachta indica leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Acoltremon
go.drugbank.com/drugs/DB19202ApprovedInvestigationalAcoltremon is under investigation in clinical trial NCT05493111 (A Long-term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512).